Immune-Related Adverse Events From Immune Checkpoint Inhibitors
Author:
Affiliation:
1. Department of Oncology; Sidney Kimmel Cancer Center at Johns Hopkins; Baltimore Maryland USA
2. Department of Medicine; Johns Hopkins University School of Medicine; Baltimore Maryland USA
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Reference74 articles.
1. Oncology meets immunology: the cancer-immunity cycle;Chen;Immunity,2013
2. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat. Rev. Cancer,2012
3. Enhancement of antitumor immunity by CTLA-4 blockade;Leach;Science,1996
4. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N. Engl. J. Med.,2010
5. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N;Larkin;Engl. J. Med.,2015
Cited by 85 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dissociation of LAG-3 inhibitory cluster from TCR microcluster by immune checkpoint blockade;Frontiers in Immunology;2024-08-21
2. Cost-effectiveness of pembrolizumab plus chemotherapy vs. chemotherapy as first-line treatment for advanced biliary tract cancer in China and the US;Frontiers in Pharmacology;2024-08-14
3. A systematic review and meta-analysis of observational studies and uncontrolled trials reporting on the use of checkpoint blockers in patients with cancer and pre-existing autoimmune disease;European Journal of Cancer;2024-08
4. Patient-reported outcomes and experiences from a prospective cohort study of older patients with cancer on checkpoint inhibitors: The ELDERS study;Journal of Geriatric Oncology;2024-06
5. Polymer-based antibody mimetics (iBodies) target human PD-L1 and function as a potent immune checkpoint blocker;Journal of Biological Chemistry;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3